Spectrum Formulation Profile
Key Indicators
- Authorised Capital ₹ 1.20 Cr
as on 10-07-2024
- Paid Up Capital ₹ 1.20 Cr
as on 10-07-2024
- Company Age 19 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 4.11 Cr
as on 10-07-2024
- Satisfied Charges ₹ 6.81 Cr
as on 10-07-2024
- Revenue 62.45%
(FY 2021)
- Profit 60.79%
(FY 2021)
- Ebitda 47.14%
(FY 2021)
- Net Worth 4510.55%
(FY 2021)
- Total Assets 36.26%
(FY 2021)
About Spectrum Formulation
The Corporate was formerly known as Spectrum Formulation Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.20 Cr and a paid-up capital of Rs 1.20 Cr.
The company currently has active open charges totaling ₹4.11 Cr. The company has closed loans amounting to ₹6.81 Cr, as per Ministry of Corporate Affairs (MCA) records.
Harsh Aggarwal, Aman Aggarwal, Shubham Gupta, and One other member serve as directors at the Company.
- CIN/LLPIN
U74140MP2005PTC017577
- Company No.
017577
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 May 2005
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Company Details
- Location
Indore, Madhya Pradesh, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Spectrum Formulation Private Limited offer?
Spectrum Formulation Private Limited offers a wide range of products and services, including Anti Infective Drugs & Medicines, Antibiotic Tablets, Capsule & Syrup, Fertilizers and Soil Additives, Micronutrient Fertilizers, Nutraceuticals & Dietary Supplements, Mineral Supplement, Common Disease Medicines, Pharmaceutical Medicine, Brain & Nervous System Drugs, Antiepileptic Drugs.
Who are the key members and board of directors at Spectrum Formulation?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Harsh Aggarwal  | Director | 11-Nov-2022 | Current |
| Aman Aggarwal | Director | 11-Nov-2022 | Current |
| Shubham Gupta | Director | 03-Jan-2023 | Current |
| Anurag Aggarwal | Director | 11-Nov-2022 | Current |
Financial Performance and Corporate Structure Insights of Spectrum Formulation.
Spectrum Formulation Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 62.45% increase. The company also saw a substantial improvement in profitability, with a 60.79% increase in profit. The company's net worth Soared by an impressive increase of 4510.55%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Spectrum Formulation?
Unlock access to Spectrum Formulation's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Atlantis Lifesciences Private LimitedActive 9 months 20 days
Harsh Aggarwal, Aman Aggarwal and 2 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 28 May 2021 | ₹3.30 Cr | Open |
Axis Bank Limited Creation Date: 28 May 2021 | ₹5.00 M | Open |
Axis Bank Limited Creation Date: 28 May 2021 | ₹3.11 M | Open |
How Many Employees Work at Spectrum Formulation?
Spectrum Formulation has a workforce of 22 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Spectrum Formulation, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Spectrum Formulation's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
